Pharmacological significance of glycosylation in therapeutic proteins
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Glycosylation and the Immune System
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., & Dwek, R. A. (2001) · Science · doi:10.1126/science.291.5512.2370 · Cited by 1,588 · cited 1×
“These modifications are of general importance for many biological processes such as stability and folding assistance, embryonic development, antigenic and microbial recognition, inflammatory response and metastasis [24–26].”
BackgroundCetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413 · cited 1×
“Carbohydrate heterogeneity, particularly core fucosylation or the presence of bisecting N-acetylglucosamine, is known to modulate the activity of effector cells in the blood and of the antibody to affect NK cell-mediated killing [6,7,41–43,44 ].”
BackgroundGlycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764 · cited 1×
“Carbohydrate heterogeneity, particularly core fucosylation or the presence of bisecting N-acetylglucosamine, is known to modulate the activity of effector cells in the blood and of the antibody to affect NK cell-mediated killing [6,7,41–43,44 ].”
BackgroundYamane‐Ohnuki, N., Kinoshita, S., Inoue‐Urakubo, M., Kusunoki, M., Iida, S., Nakano, R., Wakitani, M., Niwa, R., Sakurada, M., Uchida, K., et al. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20151 · Cited by 572
Humanization of yeast to produce complex terminally sialylated glycoproteins
Hamilton, S. R., Davidson, R. C., Sethuraman, N., Nett, J. H., Jiang, Y., Rios, S., Bobrowicz, P., Stadheim, T. A., Li, H., Choi, B.-K., et al. (2006) · Science · doi:10.1126/science.1130256 · Cited by 511
Self-citationAdvances in the production of human therapeutic proteins in yeasts and filamentous fungi
Gerngross, T. U. (2004) · Nature Biotechnology · doi:10.1038/nbt1028 · Cited by 409
Cited by
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Higel, F., Seidl, A., Sörgel, F., & Friess, W. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.01.005 · Cited by 360
Enzymes in the Synthesis of Glycoconjugates
Schmaltz, R. M., Hanson, S. R., & Wong, C.-H. (2011) · Chemical Reviews · doi:10.1021/cr200113w · Cited by 283
Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges
Vugmeyster, Y. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i4.73 · Cited by 242
Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells
Croset, A., Delafosse, L., Gaudry, J.-P., Arod, C., Glez, L., Losberger, C., Begue, D., Krstanovic, A., Robert, F., Vilbois, F., et al. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.06.038 · Cited by 221
Tibbitts, J., Canter, D., Graff, R., Smith, A., & Khawli, L. A. (2016) · mAbs · doi:10.1080/19420862.2015.1115937 · Cited by 209
“This interesting, but highly complex, topic is outside the scope of this review and interested readers are directed to some excellent reviews on the subject.(56,57) The amount and nature of glycosylation can dramatically affect the behavior of the proteins.”
BackgroundBareither, R., & Pollard, D. (2011) · Biotechnology Progress · doi:10.1002/btpr.522 · Cited by 205
“The therapeutic efficiency of many antibodies is influenced from the N-linked glycosylation which modulate the interaction with specific Fc receptors, and determine antibody dependent cytotoxicity (ADCC) function.(17) These complex glycoproteins are sus-”
BackgroundHalf-life extended biotherapeutics
Kontermann, R. E. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1165661 · Cited by 191
“of glycosylation to half-life and in vivo efficacy has been reported.[11] Besides extending half-life and reducing clearance, glycosylation can affect activity and binding properties and can thus modulate the in vivo efficacy by altering the balance between potency and exposure time.”
BackgroundExploiting metabolic glycoengineering to advance healthcare
Agatemor, C., Buettner, M. J., Ariss, R., Muthiah, K., Saeui, C. T., & Yarema, K. J. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0126-y · Cited by 183
Picanco-Castro, V., Biaggio, R., Cova, D., & Swiech, K. (2013) · Protein & Peptide Letters · doi:10.2174/092986652012131112130322 · Cited by 34
“Despite the glycosylation process is long and used to be considered to be minor importance, we now know that glycosylation affects several essential functions of the protein [27-31].”
BackgroundEvaluation of the OSCAR™ system for the production of monoclonal antibodies by CHO-K1 cells
Costa, A. R., Rodrigues, M. E., Henriques, M., Melton, D., Cunnah, P., Oliveira, R., & Azeredo, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.028 · Cited by 12
Traylor, M. J., Bernhardt, P., Tangarone, B. S., & Varghese, J. (2018) · Biopharmaceutical Processing · doi:10.1016/b978-0-08-100623-8.00047-5 · Cited by 1
Metadata
- Authors
- Li, H., & d’Anjou, M.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 20
- Issue
- 6
- Pages
- 678-684
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W2076709027
- Cited by
- 231
- References
- 13
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.